Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
- PMID: 21901413
- PMCID: PMC3180560
- DOI: 10.1007/s00787-011-0206-0
Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
Abstract
DAYAS is a new two-part rating scale that assesses: (1) ADHD and ODD symptoms (externalising symptom ratings) and (2) symptomatology potentially related to ADHD medication (potentially medication-related symptoms) in real-world settings at different time periods throughout a normal school day. Data from a proof-of-concept study and two observational trials (Medikinet(®) retard [methylphenidate] and the Equasym XL(®) [methylphenidate] OBSEER study) evaluated: (1) validity of weekly externalising symptom ratings using DAYAS, in place of daily ratings; (2) reliability and internal consistency of DAYAS ratings for externalising symptoms and potentially medication-related symptoms; and (3) convergent and divergent validity of the externalising symptom ratings with existing validated scales. From the proof-of-concept study, daily scores by period of day and during the whole day correlated strongly with equivalent weekly scores (r = 0.83-0.92). Internal consistency of externalising symptom rating scales calculated from pooled data were acceptable or good by period of day (Cronbach's alpha = 0.68-0.90) and very high for whole day scores (Cronbach's alpha = 0.88-0.95). Internal consistency of the rating scale for potentially medication-related symptoms was also good for both teacher and parent ratings. From OBSEER data, correlations between FBB-ADHD total symptom scores and ratings on both parent and teacher versions of DAYAS were high (r = 0.73 and r = 0.84, respectively). Correlations between DAYAS and SDQ were highest for the SDQ subscales hyperactivity and conduct problems and substantially lower for pro-social behaviour, peers and emotional problems. The DAYAS rating scale had good internal consistency, and DAYAS scores correlated well with existing validated scales and the SDQ subscales hyperactivity and conduct problems. Weekly DAYAS scores (whole day and by period of day) could be considered a suitable replacement for daily assessment scores.
Figures

Similar articles
-
What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale.Eur Child Adolesc Psychiatry. 2011 Oct;20 Suppl 2(Suppl 2):S297-307. doi: 10.1007/s00787-011-0207-z. Eur Child Adolesc Psychiatry. 2011. PMID: 21901412 Free PMC article.
-
An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes.Eur Child Adolesc Psychiatry. 2011 Oct;20 Suppl 2(Suppl 2):S277-88. doi: 10.1007/s00787-011-0205-1. Eur Child Adolesc Psychiatry. 2011. PMID: 21901414 Free PMC article.
-
An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety.Eur Child Adolesc Psychiatry. 2011 Oct;20 Suppl 2(Suppl 2):S243-55. doi: 10.1007/s00787-011-0202-4. Eur Child Adolesc Psychiatry. 2011. PMID: 21901417 Free PMC article.
-
Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.CNS Drugs. 2009 Dec;23(12):1057-83. doi: 10.2165/11201140-000000000-00000. CNS Drugs. 2009. PMID: 19958043 Review.
-
[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].Encephale. 2005 May-Jun;31(3):337-48. doi: 10.1016/s0013-7006(05)82399-1. Encephale. 2005. PMID: 16142049 Review. French.
Cited by
-
Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder.Neuropsychiatr Dis Treat. 2020 Jul 1;16:1619-1643. doi: 10.2147/NDT.S248685. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32669845 Free PMC article.
-
What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale.Eur Child Adolesc Psychiatry. 2011 Oct;20 Suppl 2(Suppl 2):S297-307. doi: 10.1007/s00787-011-0207-z. Eur Child Adolesc Psychiatry. 2011. PMID: 21901412 Free PMC article.
-
The Acute and Long-Term Benefits of the Oligoantigenic Diet for Children and Adolescents on the Three Symptom Subdomains of ADHD: Inattention, Hyperactivity, and Impulsivity.Nutrients. 2025 Jun 3;17(11):1916. doi: 10.3390/nu17111916. Nutrients. 2025. PMID: 40507185 Free PMC article.
-
Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers.J Child Adolesc Psychopharmacol. 2015 Sep;25(7):558-65. doi: 10.1089/cap.2014.0160. Epub 2015 Jul 7. J Child Adolesc Psychopharmacol. 2015. PMID: 26151738 Free PMC article.
-
Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet(®) retard and Concerta(®)--a randomized, controlled, double-blind multicenter clinical crossover trial.J Child Adolesc Psychopharmacol. 2011 Oct;21(5):445-54. doi: 10.1089/cap.2010.0082. Epub 2011 Jul 26. J Child Adolesc Psychopharmacol. 2011. PMID: 21790298 Free PMC article. Clinical Trial.
References
-
- Bruhl B, Döpfner M, Lehmkuhl G (2000) Der Fremdbeurteilungsbogen für hyperkinetische Störungen (FBB-HKS)—Prävalenz hyperkinetischer Störrungen im Elternurteil und psychometrische Kriterien. Kindheit und Entwicklung 9:116–126
-
- Conners CK. Conners’ rating scales—revised. Multi-Health Systems Inc, New York: Technical manual; 1997.
-
- CTADD (2010) Guide to an outpatient medication assessment. http://ccf.buffalo.edu/pdf/MedAsses.pdf. Date Accessed 22-12-2010
-
- Döpfner M, Lehmkuhl G, Steinhausen HC. Diagnostische Verfahren, Kinder-Diagnostik-System (KIDS), Band 1: Aufmerksamkeitsdefizit- und Hyperaktivitätsstörungen (ADHS) Göttingen: Hogrefe; 2006.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical